2Andrawiss M.Cervical cancer vaccines available in 2007[J].Drug Discov Today,2005,10(14):949-950.
3Jemal A,Siegel R,Ward E,et al.Cancer statistics,2008[J].CA Cancer J Clin,2008,58(2):71-96.
4Bulk S,Berkhof J,Bulkmans NW,et al.Preferential risk of HPV 16 for squarnous cell carcinoma and of HPV18 for adenoearcinoma of the cervix compared to women with normal cytology in The Netherlands[J].Br J Cancer,2006,94(1):171-175.
5Woodman CB,Collins S,Winter H,et al.Natural history of cervical human papillomavirus infection in young women:a longitudinal cohort study[J].Lancet,2001,357(9271):1831-1836.
6Clifford GM,Gallus S,Herrero R,et al.Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys:a pooled analysis[J].Lancet,2005,366 (9490):991-998.
7Plummer M,Schiffman M,Castle PE,et al.A 2-year prospective study of human papillomaviras persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamons intraepithelial lesion[J].J Infect Dis,2007,195 (I 1):1582-1589.
